TransEnterix, Inc.
Sep 12, 2017
PDF

TransEnterix to Participate in Two Upcoming Healthcare Conferences

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC) announced today that Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at two upcoming investor conferences:

About TransEnterix

TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The company is focused on the commercialization of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The company is also developing the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform. The Senhance Surgical Robotic System has been granted a CE Mark, and is currently under FDA review for clearance in the United States. For more information, visit the TransEnterix website at www.transenterix.com.

For TransEnterix, Inc.
Investor Contact:
Mark Klausner, +1-443-213-0501
invest@transenterix.com
or
Media Contacts:
For EU: Conrad Harrington, +44 (0)20 3178 8914
or
For US: Hannah Dunning, +1-415-618-8750
TransEnterix-SVC@sardverb.com

Source: TransEnterix

News Provided by Acquire Media